BE788516A
(fr)
|
1971-09-10 |
1973-03-07 |
Lonza Ag |
Procede de fabrication d'esters alcoxyacetylacetiques
|
GB1528382A
(en)
|
1974-12-26 |
1978-10-11 |
Teijin Ltd |
Cyclopentene diols and acyl esters thereof and processes for their preparation
|
DE2658401A1
(de)
|
1976-12-23 |
1978-07-06 |
Merck Patent Gmbh |
Cyclopentan-1-amine, verfahren zu ihrer herstellung und diese verbindungen enthaltende mittel
|
US4575694A
(en)
|
1984-03-05 |
1986-03-11 |
Allied Corporation |
Coaxial connector
|
DE3900736A1
(de)
|
1989-01-12 |
1990-07-26 |
Hoechst Ag |
Positiv arbeitendes strahlungsempfindliches gemisch enthaltend einen mehrfunktionellen (alpha)-diazo-(beta)-ketoester, verfahren zu dessen herstellung und strahlungsempfindliches aufzeichnungsmaterial enthaltend dieses gemisch
|
US5914331A
(en)
|
1990-02-01 |
1999-06-22 |
Emory University |
Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane
|
US6703396B1
(en)
|
1990-02-01 |
2004-03-09 |
Emory University |
Method of resolution and antiviral activity of 1,3-oxathiolane nuclesoside enantiomers
|
US5204466A
(en)
|
1990-02-01 |
1993-04-20 |
Emory University |
Method and compositions for the synthesis of bch-189 and related compounds
|
DE4014649A1
(de)
|
1990-05-08 |
1991-11-14 |
Hoechst Ag |
Neue mehrfunktionelle verbindungen mit (alpha)-diazo-ss-ketoester- und sulfonsaeureester-einheiten, verfahren zu ihrer herstellung und deren verwendung
|
GB9301000D0
(en)
|
1993-01-20 |
1993-03-10 |
Glaxo Group Ltd |
Chemical compounds
|
US5922695A
(en)
|
1996-07-26 |
1999-07-13 |
Gilead Sciences, Inc. |
Antiviral phosphonomethyoxy nucleotide analogs having increased oral bioavarilability
|
SE9702772D0
(sv)
|
1997-07-22 |
1997-07-22 |
Astra Pharma Prod |
Novel compounds
|
US5935946A
(en)
|
1997-07-25 |
1999-08-10 |
Gilead Sciences, Inc. |
Nucleotide analog composition and synthesis method
|
AU1403099A
(en)
|
1997-11-14 |
1999-06-07 |
Merck & Co., Inc. |
Alpha-1a adrenergic receptor antagonists
|
CA2346108A1
(en)
|
1998-11-09 |
2000-05-18 |
James Black Foundation Limited |
Gastrin and cholecystokinin receptor ligands
|
GB2345058A
(en)
|
1998-12-01 |
2000-06-28 |
Cerebrus Pharm Ltd |
Hydroxypyridone compounds useful in the treatment of oxidative damage to the central nervous system
|
IL143958A0
(en)
|
1998-12-25 |
2002-04-21 |
Shionogi & Co |
Heteroaromatic derivatives having an inhibitory activity against hiv integrase
|
US20040039060A1
(en)
|
2000-06-14 |
2004-02-26 |
Ryuichi Kiyama |
Inhibitor for enzyme having two divalent metal ions as active centers
|
ES2572030T3
(es)
|
2001-08-10 |
2017-07-19 |
Shionogi & Co., Ltd. |
Agente antiviral
|
US6727275B2
(en)
|
2001-10-03 |
2004-04-27 |
Ucb, S.A./N.V. |
Pyrrolidinone derivatives
|
GEP20063848B
(en)
|
2001-10-26 |
2006-06-12 |
Inst Di Richerche Di Biolog Moltcolare P Angeletti Spa |
N-substituted hydroxypyrimi-dinone carboxamide inhibitors of hiv integrase
|
US7176217B2
(en)
|
2001-11-13 |
2007-02-13 |
Shiseido Co., Ltd. |
Azabicyclo compound matrix metalloprotease inhibitor and skin preparation
|
AU2003248872A1
(en)
|
2002-07-09 |
2004-01-23 |
Bristol-Myers Squibb Company |
Hiv integrase inhibitors
|
AU2003267098B2
(en)
|
2002-09-11 |
2008-11-20 |
Merck & Co., Inc. |
Dihydroxypyridopyrazine-1,6-dione compounds useful as HIV integrase inhibitors
|
BRPI0306214B1
(pt)
|
2002-11-20 |
2017-08-08 |
Japan Tobacco Inc. |
4-oxoquinoline compound and use of this as a hiv integrase inhibitor
|
ES2308136T3
(es)
|
2003-01-14 |
2008-12-01 |
Gilead Sciences, Inc. |
Composiciones y procedimientos para la politerapia antiviral.
|
TW200510425A
(en)
|
2003-08-13 |
2005-03-16 |
Japan Tobacco Inc |
Nitrogen-containing fused ring compound and use thereof as HIV integrase inhibitor
|
TW200528440A
(en)
|
2003-10-31 |
2005-09-01 |
Fujisawa Pharmaceutical Co |
2-cyanopyrrolidinecarboxamide compound
|
JP2007519735A
(ja)
|
2004-01-30 |
2007-07-19 |
メルク エンド カムパニー インコーポレーテッド |
Hivインテグラーゼ阻害剤として有用であるn−ベンジル−3,4−ジヒドロキシピリジン−2−カルボキサミド及びn−ベンジル−2,3−ジヒドロキシピリジン−4−カルボキサミド化合物
|
AU2005220767A1
(en)
|
2004-03-09 |
2005-09-22 |
Merck & Co., Inc. |
HIV integrase inhibitors
|
EP1755586A2
(en)
|
2004-04-29 |
2007-02-28 |
The Regents of the University of California |
Hydroxypyridinone, hydroxypyridinethione, pyrone, and thiopyrone metalloprotein inhibitors
|
WO2005110399A2
(en)
|
2004-04-29 |
2005-11-24 |
The Regents Of The University Of California |
Zinc-binding groups for metalloprotein inhibitors
|
CN1964975B
(zh)
|
2004-05-07 |
2011-11-30 |
默沙东公司 |
Hiv整合酶抑制剂
|
US7273859B2
(en)
|
2004-05-12 |
2007-09-25 |
Bristol-Myers Squibb Company |
HIV integrase inhibitors: cyclic pyrimidinone compounds
|
MY134672A
(en)
|
2004-05-20 |
2007-12-31 |
Japan Tobacco Inc |
Stable crystal of 4-oxoquinoline compound
|
WO2005113509A1
(en)
|
2004-05-20 |
2005-12-01 |
Japan Tobacco Inc. |
Novel 4-oxoquinoline compound and use thereof as hiv integrase inhibitor
|
WO2005112930A1
(en)
|
2004-05-21 |
2005-12-01 |
Japan Tobacco Inc. |
Combinations comprising a 4-isoquinolone derivative and anti-hiv agents
|
CN101014572B
(zh)
|
2004-09-15 |
2011-07-06 |
盐野义制药株式会社 |
具有hiv整合酶抑制活性的氨基甲酰基吡啶酮衍生物
|
WO2006066414A1
(en)
|
2004-12-23 |
2006-06-29 |
Virochem Pharma Inc. |
Hydroxydihydropyridopy razine-1,8-diones and methods for inhibiting hiv integrase
|
EP1852434B1
(en)
|
2005-02-21 |
2011-07-13 |
Shionogi Co., Ltd. |
Bicyclic carbamoylpyridone derivative having hiv integrase inhibiting activity
|
EP3372281B1
(en)
|
2005-04-28 |
2021-07-07 |
VIIV Healthcare Company |
Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activity
|
EP1888581A2
(en)
|
2005-05-16 |
2008-02-20 |
Gilead Sciences, Inc. |
Hiv-integrase inhibitor compounds
|
JP2009502964A
(ja)
|
2005-07-27 |
2009-01-29 |
ギリアード サイエンシーズ, インコーポレイテッド |
Hivを阻害するための抗ウイルス性ホスホン酸結合体
|
US8188271B2
(en)
|
2005-10-27 |
2012-05-29 |
Shionogi & Co., Ltd. |
Polycyclic carbamoylpyridone derivative having HIV integrase inhibitory activity
|
EP1976517A1
(en)
|
2005-12-30 |
2008-10-08 |
Gilead Sciences, Inc. |
Methods for improving the pharmacokinetics of hiv integrase inhibitors
|
EP2452682A1
(en)
|
2006-02-01 |
2012-05-16 |
Japan Tobacco, Inc. |
Use of 6-(3-chloro-2-fluorobenzyl)-1-[(2s)-1-hydroxy-3-methylbutan-2-yl]-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid or salt thereof for treating retrovirus infection
|
IN2014CN00613A
(US20040106767A1-20040603-C00005.png)
|
2006-03-06 |
2015-08-21 |
Japan Tobacco Inc |
|
US8420821B2
(en)
|
2006-03-06 |
2013-04-16 |
Japan Tobacco Inc. |
Process for production of 4-oxoquinoline compound
|
US7893055B2
(en)
|
2006-06-28 |
2011-02-22 |
Bristol-Myers Squibb Company |
HIV integrase inhibitors
|
AU2007275805A1
(en)
|
2006-07-19 |
2008-01-24 |
University Of Georgia Research Foundation, Inc. |
Pyridinone diketo acids: Inhibitors of HIV replication in combination therapy
|
CN101528749B
(zh)
|
2006-09-07 |
2013-07-31 |
工业研究有限公司 |
核苷磷酸化酶和水解酶的无环胺抑制剂
|
PT2069280E
(pt)
|
2006-09-12 |
2015-06-08 |
Gilead Sciences Inc |
Processo e intermediários para preparar inibidores de integrase de vih
|
US20100216834A1
(en)
|
2006-10-18 |
2010-08-26 |
Isaacs Richard C A |
Hiv integrase inhibitors
|
ES2601820T3
(es)
|
2007-02-23 |
2017-02-16 |
Gilead Sciences, Inc. |
Moduladores de propiedades terapéutica de las farmacocinéticas
|
US20080280945A1
(en)
|
2007-05-09 |
2008-11-13 |
Sachin Lohani |
Crystalline forms of an HIV integrase inhibitor
|
US20110009411A1
(en)
|
2007-06-29 |
2011-01-13 |
Gilead Sciences ,Inc. |
Therapeutic compositions and the use thereof
|
KR20100040892A
(ko)
|
2007-06-29 |
2010-04-21 |
길리애드 사이언시즈, 인코포레이티드 |
치료 조성물 및 그의 용도
|
AR068403A1
(es)
|
2007-09-11 |
2009-11-18 |
Gilead Sciences Inc |
Proceso e intermediarios para la preparacion de inhibidores de integrasa
|
EA201200631A1
(ru)
|
2007-11-16 |
2012-11-30 |
Джилид Сайенсиз, Инк. |
Ингибиторы репликации вируса иммунодефицита человека
|
US8129398B2
(en)
|
2008-03-19 |
2012-03-06 |
Bristol-Myers Squibb Company |
HIV integrase inhibitors
|
US20100272811A1
(en)
|
2008-07-23 |
2010-10-28 |
Alkermes,Inc. |
Complex of trospium and pharmaceutical compositions thereof
|
ES2395705T3
(es)
|
2008-07-25 |
2013-02-14 |
Glaxosmithkline Llc |
Compuestos químicos
|
WO2010011819A1
(en)
|
2008-07-25 |
2010-01-28 |
Smithkline Beecham Corporation |
Chemical compounds
|
WO2010011818A1
(en)
|
2008-07-25 |
2010-01-28 |
Smithkline Beecham Corporation |
Chemical compounds
|
CN105198804B
(zh)
|
2008-07-25 |
2018-03-23 |
盐野义制药株式会社 |
用作hiv整合酶抑制剂的化合物
|
EP2320908B9
(en)
|
2008-07-25 |
2014-06-18 |
VIIV Healthcare Company |
Dolutegravir Prodrugs
|
WO2010011815A1
(en)
|
2008-07-25 |
2010-01-28 |
Smithkline Beecham Corporation |
Chemical compounds
|
BRPI0923217A2
(pt)
|
2008-12-11 |
2017-05-23 |
Glaxosmithkline Llc |
processos para a preparação de um composto de piridona, e para a preparação de uma forma cristalina, composto, sal ou um hidrato deste, forma cristalina de um sal de sódio ou um hidrato deste, e, composição farmacêutica.
|
TWI518084B
(zh)
|
2009-03-26 |
2016-01-21 |
鹽野義製藥股份有限公司 |
哌喃酮與吡啶酮衍生物之製造方法
|
US8338441B2
(en)
|
2009-05-15 |
2012-12-25 |
Gilead Sciences, Inc. |
Inhibitors of human immunodeficiency virus replication
|
WO2011028044A2
(ko)
|
2009-09-02 |
2011-03-10 |
이화여자대학교 산학협력단 |
피라졸 유도체, 이의 제조방법 및 이를 포함하는 골다공증 예방 및 치료용 조성물
|
US20120295898A1
(en)
|
2010-01-27 |
2012-11-22 |
Mark Richard Underwood |
Antiviral Therapy
|
SG183484A1
(en)
|
2010-02-26 |
2012-09-27 |
Japan Tobacco Inc |
1,3,4,8-tetrahydro-2h-pyrido[1,2-a]pyrazine derivative and use of same as hiv integrase inhibitor
|
TWI582097B
(zh)
|
2010-03-23 |
2017-05-11 |
Viiv醫療保健公司 |
製備胺甲醯吡啶酮衍生物及中間體之方法
|
US20130165489A1
(en)
|
2010-05-03 |
2013-06-27 |
The Trustees Of The University Of Pennsylvania |
Small Molecule Modulators of HIV-1 Capsid Stability and Methods Thereof
|
MA34397B1
(fr)
|
2010-07-02 |
2013-07-03 |
Gilead Sciences Inc |
Dérivés d'acide napht-2-ylacétique dans le traitement du sida
|
PE20130525A1
(es)
|
2010-07-02 |
2013-05-05 |
Gilead Sciences Inc |
Derivados de acido 2 quinolinil acetico como compuestos antivirales frente a vih
|
ES2870006T3
(es)
|
2010-08-05 |
2021-10-26 |
Shionogi & Co |
Procedimiento para producir compuestos que tienen actividad inhibidora de la integrasa del HIV
|
AU2011307087B2
(en)
|
2010-09-24 |
2016-11-10 |
Shionogi & Co., Ltd. |
Substituted polycyclic carbamoyl pyridone derivative prodrug
|
CA2833377C
(en)
|
2011-04-21 |
2019-02-12 |
Gilead Sciences, Inc. |
Benzothiazole compounds and their pharmaceutical use
|
WO2012151361A1
(en)
|
2011-05-03 |
2012-11-08 |
Concert Pharmaceuticals Inc. |
Carbamoylpyridone derivatives
|
US9328075B2
(en)
|
2011-05-05 |
2016-05-03 |
St. Jude Children's Research Hospital |
Pyrimidinone compounds and methods for treating influenza
|
WO2013006738A1
(en)
|
2011-07-06 |
2013-01-10 |
Gilead Sciences, Inc. |
Compounds for the treatment of hiv
|
CN102863512B
(zh)
|
2011-07-07 |
2016-04-20 |
上海泓博智源医药技术有限公司 |
抗病毒化合物
|
EP2742051B1
(en)
|
2011-09-14 |
2016-10-12 |
Mapi Pharma Limited |
Amorpous form of the dolutegravir sodium salt
|
WO2013054862A1
(ja)
|
2011-10-12 |
2013-04-18 |
塩野義製薬株式会社 |
インテグラーゼ阻害活性を有する多環性ピリドン誘導体
|
WO2013090929A1
(en)
|
2011-12-15 |
2013-06-20 |
Gilead Sciences, Inc. |
Amino quinoline derivatives inhibitors of hcv
|
PE20141558A1
(es)
|
2012-04-20 |
2014-11-06 |
Gilead Sciences Inc |
Derivados de acido benzotiazol-6-il acetico y su uso para tratar una infeccion por vih
|
WO2014008636A1
(en)
|
2012-07-11 |
2014-01-16 |
Merck Sharp & Dohme Corp. |
Macrocyclic compounds as hiv integrase inhibitors
|
WO2014014933A1
(en)
|
2012-07-20 |
2014-01-23 |
Merck Sharp & Dohme Corp. |
Hiv treatment with amido-substituted pyrimidinone derivatives
|
US20150218164A1
(en)
|
2012-07-25 |
2015-08-06 |
Merck Sharp & Dohme Corp. |
Substituted naphthyridinedione derivatives as hiv integrase inhibitors
|
BR112015002275A2
(pt)
|
2012-08-03 |
2017-07-04 |
Gilead Sciences Inc |
processos e intermediários para a preparação de inibidores da integrase
|
KR20150093819A
(ko)
|
2012-12-14 |
2015-08-18 |
글락소스미스클라인 엘엘씨 |
약제 조성물
|
WO2014099586A1
(en)
|
2012-12-17 |
2014-06-26 |
Merck Sharp & Dohme Corp. |
4-pyridinonetriazine derivatives as hiv integrase inhibitors
|
US20140221355A1
(en)
|
2012-12-21 |
2014-08-07 |
Gilead Sciences, Inc. |
Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
|
MD4841B1
(ro)
*
|
2012-12-21 |
2023-01-31 |
Gilead Sciences, Inc. |
Compuşi policiclici de carbamoilpiridonă şi utilizarea lor farmaceutică
|
WO2014100077A1
(en)
|
2012-12-21 |
2014-06-26 |
Merck Sharp & Dohme Corp. |
Gastro-retentive formulations
|
RU2015131006A
(ru)
|
2012-12-27 |
2017-01-30 |
Джапан Тобакко Инк. |
ЗАМЕЩЕННОЕ ПРОИЗВОДНОЕ СПИРОПИРИДО[1,2-a]ПИРАЗИНА И ЕГО ПРИМЕНЕНИЕ В МЕДИЦИНЕ В КАЧЕСТВЕ ИНГИБИТОРА ИНТЕГРАЗЫ ВИРУСА ИММУНОДЕФИЦИТА ЧЕЛОВЕКА (ВИЧ)
|
US9951079B2
(en)
*
|
2013-06-13 |
2018-04-24 |
Merck Sharp & Dohme Corp. |
Fused tricyclic heterocyclic compounds as HIV integrase inhibitors
|
EP3252058B1
(en)
*
|
2013-07-12 |
2021-01-20 |
Gilead Sciences, Inc. |
Polycyclic-carbamoylpyridone compounds and their use for the treatment of hiv infections
|
NO2865735T3
(US20040106767A1-20040603-C00005.png)
*
|
2013-07-12 |
2018-07-21 |
|
|
WO2015039348A1
(en)
*
|
2013-09-23 |
2015-03-26 |
Merck Sharp & Dohme Corp. |
Tetracyclic heterocycle compounds useful as hiv integrase inhibitors
|
EA030695B1
(ru)
|
2013-09-27 |
2018-09-28 |
Мерк Шарп И Доум Корп. |
Замещенные производные хинолизина, которые можно использовать как ингибиторы интегразы вич
|
WO2015089847A1
(en)
|
2013-12-20 |
2015-06-25 |
Merck Sharp & Dohme Corp. |
Spirocyclic heterocycle compounds useful as hiv integrase inhibitors
|